MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CNSP has $8,623,466 in assets. $4,100,910 in debts. $7,201,014 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
197.59%
Quick Ratio
197.59%
Cash Ratio
175.60%
Debt to Asset Ratio
47.56%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Prepaid expenses, net of current...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
7,201,014
Deferred offering costs
45,486
Subscription receivable
0
Prepaid expenses and other current assets
856,301
Total current assets
8,102,801
Prepaid expenses, net of current portion
502,962
Property and equipment, net
17,703
Total noncurrent assets
520,665
Total assets
8,623,466
Accounts payable and accrued expenses
3,772,339
Notes payable
328,571
Total current liabilities
4,100,910
Total liabilities
4,100,910
Common stock, 0.001 par value, 300,000,000 shares authorized and 632,516 and 117,796 shares issued and outstanding, respectively
633
Additional paid-in capital
104,797,191
Accumulated deficit
-100,275,268
Total stockholders' equity (deficit)
4,522,556
Total liabilities and stockholders' equity (deficit)
8,623,466
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$7,201,014 Prepaid expenses andother current assets$856,301 Deferred offering costs$45,486 Prepaid expenses, net ofcurrent portion$502,962 Property and equipment,net$17,703 Total current assets$8,102,801 Total noncurrentassets$520,665 Total assets$8,623,466 Total liabilities andstockholders' equity...$8,623,466 Total stockholders'equity (deficit)$4,522,556 Total liabilities$4,100,910 Accumulated deficit-$100,275,268 Additional paid-in capital$104,797,191 Total currentliabilities$4,100,910 Common stock, 0.001 parvalue, 300,000,000...$633 Accounts payable andaccrued expenses$3,772,339 Notes payable$328,571

CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals, Inc. (CNSP)